GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies

$946,062
Julien Sage · Stanford University · R35 · FY2022 · CA

Integrating tumor and stroma to understand and predict treatment response

$945,906
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · U01 · FY2022 · CA

Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer

$945,646
Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2022 · CA

Metabolic Regulators of Tumor Growth and Progression

$945,631
Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2018 · CA

Attacking stress tolerance in cancer

$945,158
David A Cheresh · University Of California, San Diego · R35 · FY2020 · CA

Determining Age-Dependent Metabolic Changes in Tumors and Their Microenvironment

$945,000
Maria M. Mihaylova · Ohio State University · DP2 · FY2024 · CA

Vermont PROSPR Research Center (VPRC)

$944,888
Brian L Sprague · University Of Vermont & St Agric College · U54 · FY2012 · CA

Novel Markers for Disease Outcome in Breast Cancer

$944,569
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Metabolic Regulators of Tumor Growth and Progression

$944,432
Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2020 · CA

Zebrafish core

$944,416
Christine Kettenhofen · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Innovations and mechanisms in tumor subcellular metabolism

$944,400
Monther Abu-Remaileh · Stanford University · DP2 · FY2024 · CA

Metabolic Regulators of Tumor Growth and Progression

$943,806
Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2021 · CA

Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma

$943,738
Richard Klinghoffer · Presage Biosciences, Inc. · R44 · FY2018 · CA

Preclinical development of Ala+TIMP-2 as an cancer therapeutic

$943,457
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Overcoming resistance to anti-PD1 immunotherapy

$943,344
Thomas F Gajewski · University Of Chicago · R35 · FY2021 · CA

Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies

$943,287
Julien Sage · Stanford University · R35 · FY2023 · CA

Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology

$942,807
David G Kirsch · Duke University · R35 · FY2018 · CA

Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology

$942,807
David G Kirsch · Duke University · R35 · FY2017 · CA

Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology

$942,807
David G Kirsch · Duke University · R35 · FY2021 · CA

Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology

$942,807
David G Kirsch · Duke University · R35 · FY2016 · CA

Cancer Center Administration

$942,425
Peter A Jones · University Of Southern California · P30 · FY2010 · CA

A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States

$942,132
Pablo Tamayo · University Of California, San Diego · U01 · FY2021 · CA

The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers

$942,000
Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2017 · CA

Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC

$941,562
Nabeel Bardeesy · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA

Overcoming resistance to anti-PD1 immunotherapy

$941,158
Thomas F Gajewski · University Of Chicago · R35 · FY2017 · CA